Blood test may prevent clots after leg surgery

NCT ID NCT07597239

Ongoing Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 4 times

Summary

This study looks at whether a special blood test (TEG-PM) can guide doctors in adjusting blood-thinning medications for people who have had leg artery surgery for peripheral artery disease. About 130 adults will have their blood tested before and up to 9 months after surgery, and their medications (aspirin, clopidogrel, or ticagrelor) may be changed based on the results. The goal is to reduce the risk of dangerous blood clots forming in the treated leg.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIAL OCCLUSIVE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arterial Occlusive Diseases peripheral arterial disease thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTERIAL OCCLUSIVE DISEASES PERIPHERAL ARTERIAL DISEASE(PAD) PLATELET INHIBITION PRU(PLATELET REACTIVITY UNIT) STENT THROMBOSIS THROMBOELASTOGRAPHY (TEG) THROMBOSIS

Contacts and locations

Show contact details

Locations

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.